“…Sequencing using other platforms is also possible but has been less well explored (e.g., Ion Torrent Proton [Thermo Fisher Scientific]; Lesur et al., ). Larger projects will be able to take advantage of lower per‐sample costs of the higher‐throughput platforms (e.g., NovaSeq 6000 [Illumina]; Gardiner et al., ). In the future, new developments in high‐throughput sequencing with longer read lengths (e.g., NovaSeq S Prime flow cell 2 × 250 bp) or single‐molecule sequencing (e.g., PacBio [Pacific Biosciences, Menlo Park, California, USA], Wolf et al., ; MinION [Oxford Nanopore Technologies, Oxford, United Kingdom], Bethune et al., ; Li et al., ) could facilitate the recovery of flanking regions, but at this time these newer sequencing platforms remain relatively unexplored for target capture projects (but see Gilpatrick et al., ; Kovaka et al., ; Payne et al., ).…”